跳至主要内容
临床试验/CTRI/2020/03/024341
CTRI/2020/03/024341尚未招募2 期

A Randomized Open Label Clinical Trial On the efficacy of Tiktaka Ghrita Tarpana, Prasadana Putapaka And Kataka Khadiradi Ghan Vati In Madumehajanya Timira With Special Reference To Diabetic Retinopathy

Director National Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Known cases of Type I and Type II diabetes mellitus
  • 2. Patients with well controlled blood sugar level
  • 3. Patients with visual symptoms like blurring of vision, floaters etc
  • 4. Patients with mild to moderate NPDR
  • 5. Patients willing to give written consent

排除标准

  • 1. Patients with severe NPDR or with PDR, Diabetic Maculopathy.
  • 2. Patients with Diabetic Retinopathy with complications like Retinal detachment, posterior vitreal detachment, acute vitreal hemorrhage, RubiosisIridis.
  • 3. Gestational Diabetic Retinopathy.
  • 4. Severe visual impairments like high Myopia, Retinitis Pigmentosa, mature Cataract, post Cataract surgeries, Glaucoma.
  • 5. Patients with other systemic complaints like Hypertension, Renal impairment, COPD, cardiovascular diseases.

研究者

发起方
Director National Institute of Ayurveda

相似试验